Metro Washington, DC; and Glenwood Springs, CO, has been selected to manage two multiple sclerosis research groups (MS), North American Imaging in Multiple Sclerosis (NAIMS) and International Multiple Sclerosis Visual System Consortium (IMSVISUAL). AMPED will provide full-service management, including meeting planning, marketing, web management, financial management and governance.

AMPED’s Emily Viles-Monari will serve as the Association Manager for both organizations.

“While these organizations are different in how they are structured, who they serve, and what they focus on, they share a vision for improving MS care,” said Viles-Monari. “I’m thrilled to be in the unique position to help them tackle that together through their specific lenses.”

“Because of our long-standing, successful partnership with the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), NAIMS and IMSVisual are a natural fit for AMPED,” said Lynda J. Patterson, FASAE, CAE, President and Owner of AMPED and CEO of ACTRIMS. “We will use what we’ve learned from ACTRIMS and our relationships with thought leaders in MS to manage and grow these MS research groups and keep them in the MS family.”

ACTRIMS provides leadership in the field of multiple sclerosis and other demyelinating diseases. Over the last ten years, AMPED has supported ACTRIMS and its international triennial meeting, as well as launched its own annual meeting with over 1,200 attendees and 250 abstracts.

The North American Imaging in Multiple Sclerosis (NAIMS) Cooperative represents a network of 30 academic centers focused on accelerating the pace of magnetic resonance imaging (MRI) research in MS through idea exchange and collaboration.

The goal of IMSVISUAL is to improve care, research and education in multiple sclerosis and other neuroinflammatory disorders by advancing our understanding of the visual system in MS.

Both groups hold an annual symposium during the ACTRIMS annual Forum.